September 22, 2020
1 min read
Save
ALLSTAR
Issue: September 2020
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Safety and efficacy of allogeneic cardiosphere-derived cells (CAP-1002, Capricor Therapeutics) to decrease infarct size in MI.